Oaktree Acquisition Corp. III Life Sciences (OACC)
NASDAQ: OACC · Real-Time Price · USD
Oaktree Acquisition Corp. III Life Sciences currently trades with the ticker symbol OACCU
10.08
+0.03 (0.30%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.

The company was incorporated in 2024 and is based in Los Angeles, California.

Oaktree Acquisition Corp. III Life Sciences
Country United States
Founded 2024
IPO Date Oct 24, 2024
Industry Shell Companies
Sector Financials
CEO Zaid Pardesi

Contact Details

Address:
333 South Grand Avenue, 28th Floor
Los Angeles, California 90071
United States
Phone 213 830 6300
Website oaktreeacquisitioncorp.com

Stock Details

Ticker Symbol OACC
Exchange NASDAQ
Reporting Currency USD
IPO Price $10.00
CIK Code 0002029769
SIC Code 6770

Key Executives

Name Position
John Frank Chairman and Director
Zaid Pardesi Chief Executive Officer
Aman Kumar Director
Mathew Pendo Chief Operating Officer
Courtney Conigliaro Chief Financial Officer

Latest SEC Filings

Date Type Title
Nov 7, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 5, 2024 8-K Current Report
Oct 31, 2024 8-K Current Report
Oct 30, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Oct 25, 2024 8-K Current Report
Oct 24, 2024 424B4 Prospectus
Oct 24, 2024 CERT Certification by an exchange approving securities for listing
Oct 23, 2024 EFFECT Notice of Effectiveness
Oct 23, 2024 8-A12B Registration of securities
Oct 18, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933